SEMA6D and osteosarcoma: Collectively, the study demonstrated that high expression of circUBAP2 and SEMA6D promotes the Wnt/β-catenin signaling pathway and cisplatin resistance, while the microRNA miR-506-3p negatively regulates circUBAP2 and SEMA6D and restrains osteosarcoma invasiveness.